CRH and Anxiety: Taken together, these results suggest that AESZS treatment during NicW curbs NicW-induced amygdaloid noradrenergic overactivation, which in turn blocks excessive excitement within the CRF/CRF1R pathway and ultimately eliminates anxiety-like behavior.